Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:administeredBy |
gptkb:Health_Resources_and_Services_Administration
|
| gptkbp:appliesTo |
covered entities
drug manufacturers |
| gptkbp:authority |
Section 340B of the Public Health Service Act
|
| gptkbp:citation |
42 CFR §10.1 et seq.
|
| gptkbp:country |
gptkb:United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
42 CFR Part 10
|
| gptkbp:partOf |
gptkb:law
|
| gptkbp:purpose |
establish requirements for the 340B Drug Pricing Program
|
| gptkbp:regulates |
340B program integrity
ceiling price calculation manufacturer civil monetary penalties |
| gptkbp:startDate |
January 5, 2017
|
| gptkbp:title |
gptkb:340B_Drug_Pricing_Program
|
| gptkbp:bfsParent |
gptkb:340B_Drug_Pricing_Program_Final_Rule
|
| gptkbp:bfsLayer |
7
|